Androgen Panel for Women on HRT: Which Tests Matter and Why One Number Is Not Enough

When women are evaluated for low libido, hair loss, acne, fatigue, or possible androgen excess, the workup is often reduced to a single testosterone result. That is tidy, but it is rarely enough. Androgens do not act as one flat number. They circulate in different fractions, bind to proteins, convert into other hormones, and behave differently at tissue level than they do on a lab printout.

That is why a fuller androgen panel can be much more useful than one isolated marker. In women, especially during menopause care or hormone therapy, the real question is usually not “Is testosterone normal?” It is “What is the whole androgen picture, and does it match the symptoms?”

Why one testosterone number can mislead

Total testosterone matters, but it is only the start. A woman can have a total testosterone level that looks acceptable on paper and still have symptoms if her free fraction is low, her SHBG is high, or tissue-level androgen activity is behaving differently than the serum number suggests.

The opposite is true too. A borderline lab value does not always mean clinically significant androgen excess. Context matters. Symptoms matter. The rest of the panel matters.

The basic androgen panel many clinicians start with

Total testosterone

Total testosterone is still a core marker, but the method matters. In women, levels are low enough that standard immunoassays can be unreliable. LC-MS/MS is generally preferred because it is more accurate at low concentrations.

Free testosterone

Free testosterone, whether measured directly or calculated from total testosterone and SHBG, is often closer to what patients actually feel. It reflects the biologically active fraction and tends to correlate better with symptoms than total testosterone alone.

SHBG

Sex hormone-binding globulin shapes how much testosterone is available to tissues. When SHBG rises, free testosterone falls. Oral estrogens can push SHBG upward, while insulin resistance and hypothyroidism can lower it. That makes SHBG one of the most useful explanation markers in a confusing hormone panel.

DHEA-S

DHEA-S helps assess adrenal androgen production. It can be useful when the question is whether symptoms are being driven more by the adrenal glands than by ovarian production or exogenous therapy.

Androstenedione

Androstenedione is a precursor to testosterone and can be especially informative in women with suspected PCOS or mixed-pattern androgen excess. It may be elevated even when testosterone is not dramatically abnormal.

DHT

Dihydrotestosterone, or DHT, matters most when symptoms are strongly androgen-sensitive, especially hair loss, acne, or hirsutism. Serum DHT is not the whole story, but ignoring it can leave obvious clues on the table.

When a deeper panel makes sense

If the clinical picture suggests tissue-level androgen excess, a broader workup may be worth it. One marker that often helps is 3α-androstanediol glucuronide, sometimes written as 3α-diol-G. It is a downstream marker of DHT activity in tissues and can be informative in androgen-related hair loss and acne.

This matters because some women have symptoms that clearly look androgen-driven even when serum DHT appears normal. In those cases, a tissue-activity marker may explain more than another repeat testosterone test.

What urine metabolites can add

Urine-based hormone testing, including DUTCH-style panels, can add another layer by showing androgen metabolites such as androsterone, etiocholanolone, and 5α- or 5β-androstanediol patterns. These results can help clinicians understand the overall volume of androgen metabolism and whether 5α-reductase activity appears to be dominant.

That can be useful when the main question is not simply how much testosterone is present, but what the body is doing with it after that. A stronger 5α pathway may fit with tissue DHT effects, which is why metabolite patterns sometimes help explain hair, skin, or symptom changes that standard bloodwork misses.

What a practical panel often looks like

For women on hormone therapy or for women with suspected androgen imbalance, a practical panel often includes total testosterone, free testosterone, SHBG, DHEA-S, androstenedione, and DHT. If symptoms suggest stronger tissue androgen effects, 3α-diol-G or androgen metabolite testing may be added.

That is a more useful approach than treating “normal testosterone” as the end of the conversation. Hormones do not work that neatly, and women deserve better than a one-number shortcut.

The clinical picture still decides what matters

Labs are there to support clinical judgment, not replace it. Hair shedding, acne, unwanted hair growth, low libido, fatigue, mood changes, and body-composition shifts all matter. So does medication context, including oral estrogen use, testosterone therapy, metabolic health, and thyroid status.

A thorough androgen panel is helpful because it gives structure to that conversation. It does not remove the need to interpret the patient in front of you.

The bottom line

A meaningful androgen workup in women usually requires more than one testosterone result. Total testosterone, free testosterone, SHBG, DHEA-S, androstenedione, and DHT each answer a different question, and tissue markers or urine metabolites can sometimes explain symptoms that blood alone does not. If the symptoms and the lab sheet do not match, the answer is often a broader panel, not blind reassurance.

This article is for educational purposes only and does not replace personal medical advice. Hormone testing and interpretation should be done with a qualified clinician who can assess symptoms, medications, metabolic context, and risk factors together.